Civic AI
Procurement intelligence
Federal contract award
RESEARCH AND DEVELOPMENT- AOI #16+ SEEKING TO MANUFACTURE AND OBTAIN REGULATORY APPROVAL FOR THE CYTOTRACKER BV, A POINT-OF-CARE INSTANT WHITE BLOOD CELL ANALYSIS PLATFORM FOR DISCRIMINATING BETWEEN ACUTE VIRAL AND BACTERIAL INFECTIONS.
RIZLAB HEALTH INC · Department of Health and Human Services
- Value
- $2,483,472
- Start
- Aug 11, 2023
- End
- Apr 10, 2027
- Action date
- Feb 9, 2026
- PIID
- 75A50123C00028
- Status
- active
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- PRINCETON, NJ
- Award type
- DEFINITIVE CONTRACT
Description
RESEARCH AND DEVELOPMENT- AOI #16+ SEEKING TO MANUFACTURE AND OBTAIN REGULATORY APPROVAL FOR THE CYTOTRACKER BV, A POINT-OF-CARE INSTANT WHITE BLOOD CELL ANALYSIS PLATFORM FOR DISCRIMINATING BETWEEN ACUTE VIRAL AND BACTERIAL INFECTIONS.
Need modifications, related awards, and vendor peers? Open the full award workspace.